£100 million a year company in the making .28 Apr 2022 10:21
I thought that was a pretty good well detailed post covid RNS .
Over 50% of business now ex U.K. .
The sales are still what many aim companies would dream for , great profit margin .
Our Q machines are closed platform for covid testing and our mygo machines open platform for all ranges of tests .
We know tata are using our mygo machines and possibly Amazon as well . They are moving into personal health POC testing in a big way now .
The mygo machines are open platform and we have many non covid tests to use going forward .
We are also planning not to compete head to head with major bio firms on existing tests and develop new and exciting world first tests , just like we did with our world first covid tests .
I am not disappointed in the closure of lab21 and microgen and lab21.
We are streamlining and getting rid of non profitable parts of the business and focussing on what we are good at .
We have plans going forward now , we are still supplying the dhsc , who and unicef .
We have a great base to build on now and our name and what we do is well known and respected by big pharma and corporations .
All to play for imo .
£100 million a year company going forward .
Easy .